| EP3524600 - PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.09.2022 Database last updated on 09.04.2026 | |
| Former | The patent has been granted Status updated on 21.10.2021 | ||
| Former | Grant of patent is intended Status updated on 22.07.2021 | ||
| Former | Examination is in progress Status updated on 02.03.2020 | ||
| Former | Request for examination was made Status updated on 13.12.2019 | ||
| Former | The application has been published Status updated on 12.07.2019 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states Sanofi 54, rue La Boétie 75008 Paris / FR | [2019/33] | Inventor(s) | 01 /
BOUABOULA, Monsif c/o SANOFI - Patent Department 55 Corporate Drive 55A-505A BRIDGEWATER, NJ 8807 / US | 02 /
BROLLO, Maurice c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 03 /
CERTAL, Victor c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 04 /
EL-AHMAD, Youssef c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 05 /
FILOCHE-ROMME, Bruno c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 06 /
HALLEY, Frank c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 07 /
MCCORT, Gary c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 08 /
SCHIO, Laurent c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 09 /
TABART, Michel c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 10 /
TERRIER, Corinne c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | 11 /
THOMPSON, Fabienne c/o SANOFI Patent Department 54, rue la Boetie 75008 PARIS / FR | [2019/33] | Representative(s) | Ipsilon 11 rue Saint-Georges 75009 Paris / FR | [N/P] |
| Former [2019/33] | Nony 11 rue Saint-Georges 75009 Paris / FR | Application number, filing date | 19164243.8 | 14.02.2017 | [2019/33] | Priority number, date | EP20160305174 | 15.02.2016 Original published format: EP 16305174 | [2019/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3524600 | Date: | 14.08.2019 | Language: | EN | [2019/33] | Type: | B1 Patent specification | No.: | EP3524600 | Date: | 17.11.2021 | Language: | EN | [2021/46] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 03.06.2019 | Classification | IPC: | C07D403/12, C07D401/12, C07D405/12, C07D413/12, C07D417/12, C07D471/04, C07D207/12, A61K31/40, A61K31/4025, A61P35/00, C07F5/02 | [2019/33] | CPC: |
C07D207/12 (EP,CN,EA,IL,KR,US);
A61K31/4025 (EA);
A61K31/4015 (KR);
A61K31/4439 (KR);
A61K31/506 (KR);
A61P13/08 (EA,IL);
A61P15/00 (EA,IL);
A61P15/08 (EA,IL);
A61P19/10 (EA,IL);
A61P29/00 (EA,IL);
A61P35/00 (CN,EA,IL,KR);
A61P35/04 (EA,IL);
A61P43/00 (EA,IL);
A61P5/32 (EA,IL);
C07D209/08 (CN);
C07D401/12 (EP,CN,EA,IL,KR,US);
C07D403/12 (EP,CN,EA,IL,KR,US);
C07D405/12 (EP,CN,EA,IL,KR,US);
C07D413/12 (EP,EA,IL,US);
C07D417/12 (EP,EA,IL,KR,US);
C07D471/04 (EP,EA,IL,KR,US);
C07F5/025 (EP,CN,EA,IL,US);
C07F5/027 (KR);
C07F7/0812 (EA,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/03] |
| Former [2019/33] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Validation states | MA | 21.03.2019 | Title | German: | VERFAHREN UND ZWISCHENPRODUKTE ZUR HERSTELLUNG VON NEUARTIGEN SUBSTITUIERTEN 6,7-DIHYDRO-5H-BENZO[7]ANNULEN-VERBINDUNGEN | [2019/33] | English: | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS | [2019/33] | French: | PROCÉDÉS ET INTERMÉDIAIRES POUR LA PRÉPARATION DE NOUVEAUX COMPOSÉS SUBSTITUÉS DE 6,7-DIHYDRO-5H-BENZO[7]ANNULÈNE | [2019/33] | Examination procedure | 06.12.2019 | Amendment by applicant (claims and/or description) | 06.12.2019 | Examination requested [2020/03] | 06.12.2019 | Date on which the examining division has become responsible | 05.03.2020 | Despatch of a communication from the examining division (Time limit: M04) | 25.06.2020 | Reply to a communication from the examining division | 26.08.2020 | Despatch of a communication from the examining division (Time limit: M02) | 05.10.2020 | Reply to a communication from the examining division | 25.11.2020 | Despatch of a communication from the examining division (Time limit: M04) | 22.02.2021 | Reply to a communication from the examining division | 23.07.2021 | Communication of intention to grant the patent | 12.10.2021 | Fee for grant paid | 12.10.2021 | Fee for publishing/printing paid | 12.10.2021 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP17705842.7 / EP3416962 | Opposition(s) | 18.08.2022 | No opposition filed within time limit [2022/43] | Fees paid | Renewal fee | 21.03.2019 | Renewal fee patent year 03 | 13.02.2020 | Renewal fee patent year 04 | 12.02.2021 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 17.11.2021 | EE | 17.11.2021 | FI | 17.11.2021 | HR | 17.11.2021 | LT | 17.11.2021 | LV | 17.11.2021 | MK | 17.11.2021 | PL | 17.11.2021 | RO | 17.11.2021 | RS | 17.11.2021 | SI | 17.11.2021 | SK | 17.11.2021 | SM | 17.11.2021 | TR | 17.11.2021 | LU | 14.02.2022 | BG | 17.02.2022 | GR | 18.02.2022 | IS | 17.03.2022 | PT | 17.03.2022 | [2024/29] |
| Former [2024/23] | AL | 17.11.2021 | |
| EE | 17.11.2021 | ||
| FI | 17.11.2021 | ||
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| MK | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RO | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SI | 17.11.2021 | ||
| SK | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| LU | 14.02.2022 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2023/01] | AL | 17.11.2021 | |
| EE | 17.11.2021 | ||
| FI | 17.11.2021 | ||
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RO | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SI | 17.11.2021 | ||
| SK | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| LU | 14.02.2022 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/49] | AL | 17.11.2021 | |
| EE | 17.11.2021 | ||
| FI | 17.11.2021 | ||
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RO | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SK | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| LU | 14.02.2022 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/47] | EE | 17.11.2021 | |
| FI | 17.11.2021 | ||
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RO | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SK | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| LU | 14.02.2022 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/35] | EE | 17.11.2021 | |
| FI | 17.11.2021 | ||
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RO | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SK | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/34] | EE | 17.11.2021 | |
| FI | 17.11.2021 | ||
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RO | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/33] | FI | 17.11.2021 | |
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| SM | 17.11.2021 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/24] | FI | 17.11.2021 | |
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| BG | 17.02.2022 | ||
| GR | 18.02.2022 | ||
| IS | 17.03.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/23] | FI | 17.11.2021 | |
| HR | 17.11.2021 | ||
| LT | 17.11.2021 | ||
| LV | 17.11.2021 | ||
| PL | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| BG | 17.02.2022 | ||
| PT | 17.03.2022 | ||
| Former [2022/22] | FI | 17.11.2021 | |
| LT | 17.11.2021 | ||
| RS | 17.11.2021 | ||
| BG | 17.02.2022 | ||
| Former [2022/21] | RS | 17.11.2021 | |
| BG | 17.02.2022 | ||
| Former [2022/19] | BG | 17.02.2022 | Documents cited: | Search | [A] WO2013097773 (CENTAURUS BIOPHARMA CO LTD et al.) | [A] ANSTEAD G M ET AL: "2,3-Diarylindenes and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, oestrogen receptor binding affinity, and comparisons with related triarylethylenes", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 31, no. 7, July 1988 (1988-07-01), pages 1316 - 1326, XP002121530, ISSN: 0022-2623, DOI: 10.1021/JM00402A011 DOI: http://dx.doi.org/10.1021/jm00402a011 | [A] MCCAGUE R ET AL: "Nonisomerisable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 31, no. 7, July 1988 (1988-07-01), pages 1285 - 1290, XP002121529, ISSN: 0022-2623, DOI: 10.1021/JM00402A005 DOI: http://dx.doi.org/10.1021/jm00402a005 | by applicant | G.M. ANSTEAD ET AL.: "2,3-diarylindenes and 2,3-diarylindenones as binders of estrogen receptors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 31, no. 7, 1988, pages 1316 - 1326 | R. MCCAGUE ET AL.: "analogues of (Z)- and (E)-4-hydroxytamoxifen and have tested their binding affinities to estrogen receptors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 31, no. 7, 1998, pages 1285 - 1290 | T.W. GREENE; P. G. M. WUTS: "Protective Groups in Organic Chemistry", 2006, JOHN WILEY AND SONS |